ValiRx Finland Overview
- Founded
- 2008
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 2
ValiRx Finland General Information
Description
Provider of medical and clinical services. The company offers research and development services for therapeutics, it manages clinical work for VAL 201, a peptide for the treatment of refractory prostate cancer.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Acquirer
Primary Office
- Elektroniikkatie 3
- 90590 Oulu
- Finland
ValiRx Finland Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore ValiRx Finland‘s full profile, request access.
Request a free trial